Indium

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Logo pink
Stay in the know!
As part of our commitment to providing the most up-to-date drug information, we will be releasing #DrugBankUpdates with our newly added curated drug pages.
#DrugBankUpdates
Name
Indium
Accession Number
DB11659
Type
Small Molecule
Groups
Investigational
Description

Indium has been used in trials studying the basic science of Clear Cell Renal Cell Carcinoma.

Structure
Thumb
Synonyms
  • indio
Product Ingredients
IngredientUNIICASInChI Key
Indium AcetateBNM20F6I0P25114-58-3VBXWCGWXDOBUQZ-UHFFFAOYSA-K
Indium Chloride31JB8MKF8Z10025-82-8PSCMQHVBLHHWTO-UHFFFAOYSA-K
Indium CitrateP7RCN32R8Q4194-69-8VSEUCCPAJZHJSX-UHFFFAOYSA-K
Indium NitrateWOP84073FA13770-61-1LKRFCKCBYVZXTC-UHFFFAOYSA-N
Indium Sulfate514CE39CG413464-82-9XGCKLPDYTQRDTR-UHFFFAOYSA-H
Categories
UNII
045A6V3VFX
CAS number
7440-74-6
Weight
Average: 114.818
Monoisotopic: 114.90387878
Chemical Formula
In
InChI Key
APFVFJFRJDLVQX-UHFFFAOYSA-N
InChI
InChI=1S/In
IUPAC Name
indigane
SMILES
[In]

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

References

General References
Not Available
External Links
PubChem Compound
5359967
PubChem Substance
347828029
ChemSpider
4514408
ChEBI
30430
Wikipedia
Indium

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
1Active Not RecruitingDiagnosticRenal Cell Adenocarcinoma1
1Active Not RecruitingTreatmentAdult Nasal Type Extranodal NK/T-Cell Lymphoma / Anaplastic Large Cell Lymphoma / Angioimmunoblastic T-Cell Lymphoma / Cutaneous B-Cell Non-Hodgkin Lymphoma / Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue / Hepatosplenic T-Cell Lymphoma / Intraocular Lymphoma / Nodal marginal zone B-cell lymphomas / Noncutaneous Extranodal Lymphoma / Peripheral T-Cell Lymphoma (PTCL) / Recurrent Adult Burkitt Lymphoma / Recurrent Adult Diffuse Large Cell Lymphoma / Recurrent Adult Diffuse Mixed Cell Lymphoma / Recurrent Adult Diffuse Small Cleaved Cell Lymphoma / Recurrent Adult Grade III Lymphomatoid Granulomatosis / Recurrent Adult Hodgkin's Lymphoma / Recurrent Adult Immunoblastic Large Cell Lymphoma / Recurrent Adult Lymphoblastic Lymphoma / Recurrent Adult T-Cell Leukemia/Lymphoma / Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma / Recurrent Grade 1 Follicular Lymphoma / Recurrent Grade 2 Follicular Lymphoma / Recurrent Grade 3 Follicular Lymphoma / Recurrent Mantle Cell Lymphoma / Recurrent Marginal Zone Lymphoma / Recurrent Mycosis Fungoides/Sezary Syndrome / Recurrent Small Lymphocytic Lymphoma / Refractory Hairy Cell Leukemia / Small Intestine Lymphoma / Splenic Marginal Zone Lymphoma / T-Cell Large Granular Lymphocyte Leukemia / Testicular Lymphoma / Waldenström's Macroglobulinemia (WM)1
1CompletedDiagnosticColonic Neoplasms1
1CompletedTreatmentAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome / Chronic Myelomonocytic Leukemia / Previously Treated Myelodysplastic Syndromes / Recurrent Adult Acute Lymphoblastic Leukemia / Recurrent Adult Acute Myeloid Leukemia / Refractory Anemia With Excess Blasts / Secondary Acute Myeloid Leukemia (Secondary AML, sAML)1
1CompletedTreatmentNeoplasms2
1, 2RecruitingDiagnosticCarcinoma NOS / Colorectal Cancers / Gastrointestinal Cancers / Neoplasms / Peritoneal Carcinomatosis1
1, 2TerminatedDiagnosticGastroenteropancreatic Neuroendocrine Tumors1
1, 2TerminatedTreatmentMalignant Lymphomas1
2Active Not RecruitingTreatmentMalignant Lymphomas1
2CompletedTreatmentMultiple Myeloma (MM)1
2RecruitingTreatmentGlioblastomas1
2TerminatedTreatmentMalignant Lymphomas1
2, 3CompletedTreatmentNeuroendocrine Tumors1
Not AvailableActive Not RecruitingBasic ScienceCystic Fibrosis (CF)1
Not AvailableCompletedBasic ScienceClear Cell Renal Cell Carcinoma1
Not AvailableCompletedDiagnosticSarcoidosis1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
logP0ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count0ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area0 Å2ChemAxon
Rotatable Bond Count0ChemAxon
Refractivity0 m3·mol-1ChemAxon
Polarizability1.78 Å3ChemAxon
Number of Rings0ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleYesChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot Available

Taxonomy

Description
This compound belongs to the class of inorganic compounds known as homogeneous post-transition metal compounds. These are inorganic compounds containing only metal atoms,with the largest atom being a post-transition metal atom.
Kingdom
Inorganic compounds
Super Class
Homogeneous metal compounds
Class
Homogeneous post-transition metal compounds
Sub Class
Not Available
Direct Parent
Homogeneous post-transition metal compounds
Alternative Parents
Not Available
Substituents
Homogeneous post-transition metal
Molecular Framework
Not Available
External Descriptors
boron group element atom (CHEBI:30430)

Drug created on October 20, 2016 14:38 / Updated on February 06, 2020 13:11